SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention

The SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is a high-risk viral agent involved in the recent pandemic stated worldwide by the World Health Organization. The infection is correlated to a severe systemic and respiratory disease in many cases, which is clinically treated with a mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Inchingolo, Alessio Danilo, Inchingolo, Angelo Michele, Bordea, Ioana Roxana, Malcangi, Giuseppina, Xhajanka, Edit, Scarano, Antonio, Lorusso, Felice, Farronato, Marco, Tartaglia, Gianluca Martino, Isacco, Ciro Gargiulo, Marinelli, Grazia, D’Oria, Maria Teresa, Hazballa, Denisa, Santacroce, Luigi, Ballini, Andrea, Contaldo, Maria, Inchingolo, Francesco, Dipalma, Gianna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999785/
https://www.ncbi.nlm.nih.gov/pubmed/33806624
http://dx.doi.org/10.3390/microorganisms9030525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999785/
https://www.ncbi.nlm.nih.gov/pubmed/33806624
http://dx.doi.org/10.3390/microorganisms9030525

Ejemplares similares